Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
This paper reports on a prospective study conducted between June 1990 and June 1992 to determine method acceptability, user satisfaction and continuation rates for three highly effective and reversible contraceptive methods currently available in Kenya: the CuT 380A (IUCD), the injectable, Depo-Provera and the low-dose oral contraceptive pill, Microgynon. A non-randomised sample of volunteer participants was used. One thousand and seventy-six users were followed up for a period of one year or up to the time of discontinuation of the method, whichever came earlier. Analysis revealed method specific differences in users' characteristics. The OC users were younger and had fewer children than the IUCD or Depo-Provera users. The Depo-Provera users were older, and had the largest family sizes. Many OC users (almost 40%) were single, while almost three-quarters of IUCD and Depo-Provera users were married. IUCD users were also more educated compared to OC and Depo-Provera users. Survival analysis was used to calculate cumulative life table discontinuation rates by method for the 12 month period. Discontinuation rates were highest for OC users (80%) and lowest for IUCD users (20%) and intermediate for Depo-Provera users (39%). Ninety percent of OC and Depo-Provera users and 86% of IUCD users said they were satisfied with their respective methods. While OCs are among the most popular family planning methods in Kenya, they are also one of the most problematic, while IUCD has the fewest compliance problems. Service providers need to address the issue of high discontinuation rates among the young OC users.
Sekadde-Kigondu
C
C
Department of Clinical Chemistry, University of Nairobi.
Mwathe
E G
EG
Ruminjo
J K
JK
Nichols
D
D
Katz
K
K
Jessencky
K
K
Liku
J
J
D000293:Adolescent; D000328:Adult; D003271:Contraceptive Agents, Female; D003277:Contraceptives, Oral, Combined; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D007435:Intrauterine Devices, Copper; D007630:Kenya; D015993:Life Tables; D017533:Marital Status; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D017060:Patient Satisfaction; D011446:Prospective Studies; D016019:Survival Analysis
D003271:Contraceptive Agents, Female; D003277:Contraceptives, Oral, Combined; D019304:Ethinyl Estradiol-Norgestrel Combination; D017258:Medroxyprogesterone Acetate